Three related enzymes in Candida albicans achieve arginine- and agmatine-dependent metabolism that is essential for growth and fungal virulence by Schaefer, K. et al.
This is a repository copy of Three related enzymes in Candida albicans achieve arginine- 
and agmatine-dependent metabolism that is essential for growth and fungal virulence.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/165045/
Version: Published Version
Article:
Schaefer, K., Wagener, J., Ames, R.M. et al. (4 more authors) (2020) Three related 
enzymes in Candida albicans achieve arginine- and agmatine-dependent metabolism that 
is essential for growth and fungal virulence. mBio, 11 (4). 01845-20. 
https://doi.org/10.1128/mbio.01845-20
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Three Related Enzymes in Candida albicans Achieve Arginine-
and Agmatine-Dependent Metabolism That Is Essential for
Growth and Fungal Virulence
Katja Schaefer,a,b Jeanette Wagener,b,f Ryan M. Ames,g Stella Christou,b,c,d,e Donna M. MacCallum,b
Steven Bates,a Neil A. R. Gowa,b
aMedical Research Council Centre for Medical Mycology at The University of Exeter, University of Exeter, Exeter, United Kingdom
bThe Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom
cDepartment of Biomedical Sciences, Faculty of Science, University of Sheffield, Sheffield, United Kingdom
dDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom
eBateson Centre, University of Sheffield, Sheffield, United Kingdom
fAssay Development Scientist, Osler Diagnostics Limited, Oxford, United Kingdom
gDepartment of Biosciences, University of Exeter, Exeter, United Kingdom
ABSTRACT Amino acid metabolism is crucial for fungal growth and develop-
ment. Ureohydrolases produce amines when acting on L-arginine, agmatine, and
guanidinobutyrate (GB), and these enzymes generate ornithine (by arginase), pu-
trescine (by agmatinase), or GABA (by 4-guanidinobutyrase or GBase). Candida
albicans can metabolize and grow on arginine, agmatine, or guanidinobutyrate
as the sole nitrogen source. Three related C. albicans genes whose sequences
suggested that they were putative arginase or arginase-like genes were exam-
ined for their role in these metabolic pathways. Of these, Car1 encoded the only
bona fide arginase, whereas we provide evidence that the other two open read-
ing frames, orf19.5862 and orf19.3418, encode agmatinase and guanidinobu-
tyrase (Gbase), respectively. Analysis of strains with single and multiple muta-
tions suggested the presence of arginase-dependent and arginase-independent
routes for polyamine production. CAR1 played a role in hyphal morphogenesis in
response to arginine, and the virulence of a triple mutant was reduced in both
Galleria mellonella and Mus musculus infection models. In the bloodstream, argi-
nine is an essential amino acid that is required by phagocytes to synthesize ni-
tric oxide (NO). However, none of the single or multiple mutants affected host
NO production, suggesting that they did not influence the oxidative burst of
phagocytes.
IMPORTANCE We show that the C. albicans ureohydrolases arginase (Car1), agmati-
nase (Agt1), and guanidinobutyrase (Gbu1) can orchestrate an arginase-independent
route for polyamine production and that this is important for C. albicans growth and
survival in microenvironments of the mammalian host.
KEYWORDS Candida, arginase, guanidinobutyrase, agmatinase, immunity,
morphogenesis, Candida albicans, macrophages
L
-Arginine is a conditionally essential amino acid in humans that plays important roles
in cell division, wound healing, removal of ammonia from the body, immune
function, and the release of hormones (1). It is a precursor for the synthesis of nitric
oxide, which is an important antimicrobial component of the oxidative burst of immune
phagocytes (2) and is important for the regulation of blood pressure and circulation by
promoting blood vessel relaxation (3). Arginine occurs universally across all kingdoms
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of life and plays a key role in host-microbe interactions. In fungi, the arginase enzyme
contributes to the major catabolic path for L-arginine (4, 5) whereas higher eukaryotes
express arginine decarboxylase (6), which participates in an alternative (arginase-
independent) pathway for arginine catabolism. This branch of arginine metabolism
produces agmatine, the decarboxylated form of arginine, which is converted to pu-
trescine and urea by the enzyme agmatinase (Fig. 1A). With some exceptions, exem-
plified by Ceratocystis minor, Verticillium dahliae (7), Gigaspora rosea (8), and Panus
tigrinus (9), most fungi apparently do not have an arginine decarboxylase. Instead, the
majority of fungi produce putrescine via the decarboxylation of ornithine, a product of
the arginase reaction.
FIG 1 Arginase and agmatine metabolism mediated by the members of the C. albicans arginase-like gene family. (A) Simplified schematic pathway showing
the catabolic steps and products of agmatine and arginine metabolism. TCA, tricarboxylic acid. (B) Spot assay of C. albicans ureohydrolase mutants on media
containing intermediate products of the pathway as the sole nitrogen source. The inoculum and serial 10-fold dilutions of the C. albicans wild type plus single,
double, and triple mutants of orf19.3934 (CAR1), orf19.5862 (AGT1), and orf19.3418 (GBU1) were spotted onto agar plates, incubated at 30°C, and imaged after
72 h (with the exception of YPD and arginine plates, which were imaged at 48 h and 96 h, respectively). Mutant phenotypes identified were confirmed
subsequently by screening the complemented strains. Sections highlighted with a red rectangle identify reduced growth of the mutants. Representative images
of colony growth are displayed, with white lines indicating the locations where the images were taken (i.e., from different plates or from different regions of
the same plate), and were repositioned for presentation purposes.
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Very little is known about agmatine catabolism in fungi. Agmatinases belong to
the family of ureohydrolases and generate urea as a common product. This enzyme
family is characterized by their activity in catalyzing hydrolysis of the amide bond
of L-arginine, agmatine, and guanidinobutyrate (GB) via arginase, agmatinase, and
4-guanidinobutyrase (GBase), respectively. Mostly characterized in bacteria (10, 11),
agmatinases are metalloenzymes which hydrolyze agmatine to putrescine and are
crucial in the alternative pathway used to produce polyamines in addition to the
constitutive pathway using ornithine decarboxylase (ODC). Putrescine is then used
to form polyamines such as spermine or spermidine (12) or is converted to
4-aminobutyrate (GABA) via 4-aminobutyraldehyde (GABald). In humans, agmatine
is a cell signaling molecule that is involved in a number of cellular processes,
including the innate immune response (13–17). Unlike in bacteria or humans, the
functional importance of agmatine and its metabolism in fungi is not well under-
stood.
Agmatine is present in the lumen of the human gastrointestinal tract and is derived
from bacteria of the gut microflora (18), ingested food (19), or desquamated intestinal
epithelial cells (18). The opportunist pathogen Candida albicans is a normal part of the
gut microflora (20) but can also cause systemic candidiasis in immunocompromised
patients or patients that have experienced trauma and medical interventions (21). C.
albicans is able to survive and grow in a variety of microenvironments in the human
host that differ substantially in nutrient composition (22).
The rapid increase in the use of whole-genome sequencing has enabled identifica-
tion of putative arginase-like enzymes in many eukaryotes. However, gene identifica-
tion of these enzymes, based exclusively on sequence homology, does not enable
definitive predictions to be made with respect to the catalytic function of the encoded
proteins. The C. albicans genome contains an annotated gene (orf19.3934) encoding a
cytosolic arginase, CAR1 (EC 3.5.3.1), and two uncharacterized open reading frames
(ORFs), orf19.3418 and orf19.5862, which were predicted to encode secreted proteins
that display similarity to arginases (see Fig. S1A and B in the supplemental material). In
order to identify the role of these genes in C. albicans arginine and agmatine metab-
olism, we generated single, double, and triple mutants of the corresponding ORFs using
two independent knockout strategies, including the mini-URA blaster gene knockout
approach (23) and the CRISPR-Cas9 technology for gene disruption or editing (24). We
identify CAR1 as the only bona fide arginase gene in C. albicans, whereas we provide
evidence that the other two open reading frames, orf19.5862 and orf19.3418, likely
encode agmatinase (Agt1) and guanidinobutyrase (Gbu1), respectively. This arginase-
like gene family therefore contributes a set of ureohydrolases required for arginine and
agmatine utilization. We demonstrate that this gene family is important for virulence in
two independent animal infection models. Together, they play a key role in enabling C.
albicans growth and survival in microenvironments of the mammalian host.
RESULTS
C. albicans orf19.5862 and orf19.3418 function in agmatine catabolism. We
investigated the role of three gene products in Candida albicans, one that is annotated
as an arginase (Car1) and two products of ORFs (orf19.5862 and orf19.3418) with
similarity to arginase enzymes (see Fig. S1A and B in the supplemental material) but
that had not been functionally annotated. Comparative genomics (Fig. S1C) revealed
orthologues of all three ORFs in Candida dubliniensis, Candida tropicalis, Candida
parapsilosis, Candida auris, Talaromyces marneffei, Aspergillus fumigatus, and Cryptococ-
cus neoformans (see Table S1 in the supplemental material). An arginase orthologue
was present in Saccharomyces cerevisiae, Candida glabrata, and Histoplasma capsula-
tum, but no equivalent of either of the two newly identified ORFs, orf19.3418 and
orf19.5862, was identified. All three ORFs were absent in the obligate parasite Pneu-
mocystis jirovecii. In order to facilitate identification of the role of these arginase-like
genes in C. albicans, we generated single, double, and triple mutants with mutations of
the corresponding ORFs using the CRISPR-Cas9 gene editing technology (24) and the
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mini-URA blaster gene deletion method (23). Mutants created in this work are listed in
Table 1 and were ultimately named the gbu1Δ, agt1Δ, and car1Δ mutant strains,
corresponding to mutants with mutations in ORFs orf19.3418, orf19.5862, and
orf19.3934, respectively. Single mutants were created for each of the ORFs, and these
were then used to create double and triple mutants. In addition, these mutants were
complemented by reintroduction of the required wild-type genes into the null mutant
background.
We first assessed whether orf19.5862 and orf19.3418 are required for the utilization
of arginine and agmatine and their derivatives (Fig. 1A) or act in an arginase-
independent pathway. Spot assays of mutants generated by the CRISP-Cas9 system
(Fig. 1B) and the mini-URA blaster gene disruption system (Fig. S2) were performed on
minimal media containing intermediate products of those pathways as the sole nitro-
gen source (Fig. 1B; see also Fig. S2). Arginase belongs to the family of ureohydrolases,
and members of this family are involved in the conversion of arginine, agmatine, and
4-guanidinobutyrate (GB) to ornithine, putrescine, and 4-aminobutyric acid (GABA),
respectively. Urea is created as a coproduct of this metabolic pathway (25). We
therefore examined the suitability of these metabolites as potential nitrogen sources.
Yeast extract-peptone-dextrose (YPD) and minimal medium supplemented with
(NH4)2SO4 as the nitrogen source served as positive-growth controls.
C. albicans wild-type strains were grown on nitrogen-free minimal medium supple-
mented with (NH4)2SO4, ornithine, urea, arginine, agmatine, 4-guanidinobutyrate (GB),
4-aminobutyric acid (GABA), and putrescine and were shown to be able to utilize all of
these as a nitrogen source. All mutant strains were able to grow equally well on
ornithine, urea, and GABA (Fig. 1B; see also Fig. S2).
We next demonstrated that C. albicans mutants lacking CAR1 (car1Δ, gbu1Δ car1Δ,
agt1Δ car1Δ, and gbu1Δ agt1Δ car1Δ) were all affected in growth on minimal medium
containing arginine as the sole nitrogen source. These mutants, however, were not
affected with respect to their ability to grow on medium containing urea or ornithine,
the two products of the arginase reaction. None of the other mutants were affected in
TABLE 1 C. albicans strains used in this studya
Strain Genotype Source
SC5314 wt; clinical blood isolate Gillum et al. (63)
gbu1Δ-1 NGY700 As SC5314 but gbu1Δ gbu1Δ This work
gbu1Δ-2 NGY701 As SC5314 but gbu1Δ gbu1Δ This work
agt1Δ NGY702 As SC5314 but agt1Δ agt1Δ This work
gbu1Δ/agt1Δ NGY703 As SC5314 but gbu1Δ gbu1Δ agt1Δ agt1Δ This work
car1Δ NGY704 As SC5314 but car1Δ car1Δ This work
car1Δ/gbu1Δ NGY705 As SC5314 but car1Δ car1Δ gbu1Δ gbu1Δ This work
car1Δ/agt1Δ NGY706 As SC5314 but car1Δ car1Δ agt1Δ agt1Δ This work
gbu1Δ/agt1Δ/car1Δ NGY707 As SC5314 but car1Δ car1Δ gbu1Δ gbu1Δ agt1Δ agt1Δ This work
gbu1Δ/agt1Δgbu1 NGY708 gbu1Δ gbu1Δ agt1Δ agt1Δ:: GBU1 GBU1 This work
gbu1Δ/agt1Δ/car1Δgbu1 NGY709 gbu1Δ agt1Δ car1Δ:: GBU1 GBU1 This work
gbu1Δ/agt1Δ/car1Δcar1 NGY710 gbu1Δ agt1Δ car1Δ:: CAR1 CAR1 This work
gbu1Δ SBC199 As CAI4 but gbu1Δ::dpl200 gbu1Δ::dpl200 RPS1 rps1Δ::CIp10 This work
agt1Δ SBC200 As CAI4 but agt1Δ::dpl200 agt1Δ::dpl200 RPS1 rps1Δ::CIp10 This work
car1Δ SBC201 As CAI4 but car1Δ::dpl200 car1Δ::dpl200 RPS1 rps1Δ::CIp10 This work
gbu1Δ/agt1Δ SBC202 As CAI4 but gbu1Δ::dpl200 gbu1Δ::dpl200 agt1Δ::dpl200 agt1Δ::dpl200
RPS1 rps1Δ::CIp10
This work
gbu1Δ/agt1Δ/car1Δ SBC203 As CAI4 but gbu1Δ::dpl200 gbu1Δ::dpl200 agt1Δ::dpl200 agt1Δ::dpl200
car1Δ::dpl200 car1Δ::dpl200 RPS1 rps1Δ::CIp10
This work
gbu1ΔGBU1 SBC204 As CAI4 but gbu1Δ::dpl200 gbu1Δ::dpl200 RPS1 rps1Δ::CIp10-GBU1 This work
agt1ΔAGT1 SBC205 As CAI4 but agt1Δ::dpl200 agt1Δ::dpl200 RPS1 rps1Δ::CIp10-AGT1 This work
car1ΔCAR1 SBC206 As CAI4 but car1Δ::dpl200 car1Δ::dpl200 RPS1 rps1Δ::CIp10-CAR1 This work
gbu1Δ/agt1ΔGBU1/AGT1 SBC207 As CAI4 but gbu1Δ::dpl200 gbu1Δ::dpl200 agt1Δ::dpl200 agt1Δ::dpl200
RPS1 rps1Δ::CIp10-GBU1-AGT1
This work
gbu1Δ/agt1Δ/car1ΔGBU1/AGT1/CAR1 SBC208 As CAI4 but gbu1Δ::dpl200 gbu1Δ::dpl200 agt1Δ::dpl200 agt1Δ::dpl200
car1Δ::dpl200 car1Δ::dpl200 RPS1 rps1Δ::CIp10-GBU1-AGT1-CAR1
This work
aGenes (ORF number from Candida Genome Database [CGD], NCBI sequence identifier [ID]): car1 (orf19.3934; XP_721843.1), gbu1 (orf19.3418; AFP98, KHC73310.1), and
agt1 (orf19.5862; AFP99, XP_723078.1).
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growth on arginine, with the single and double mutants of GBU1 and AGT1 (orf19.3418
and orf19.5862) demonstrating clear growth (Fig. 1B). Therefore, we conclude that CAR1
alone encodes arginase activity in C. albicans.
The gbu1Δ-1 and gbu1Δ-2 single mutants represent two independent clones for the
knockout of orf19.3418. Both mutants demonstrated impaired growth on media con-
taining GB, but not GABA, as the nitrogen source, whereas mutants with mutations in
AGT1 (orf19.5862) or CAR1 exhibited wild-type growth on both (Fig. 1B). Furthermore,
the double and triple mutants that lacked orf19.3418 (GBU1) also displayed a growth
defect on GB but not GABA. This suggests that orf19.3418 (GBU1) is likely to encode a
GBase, required for the conversion of GB to GABA.
Single mutants with mutations in orf19.5862 (AGT1) could utilize all nitrogen sources
tested; however, the double mutant lacking both orf19.5862 and orf19.3418 (gbu1Δ
agt1Δ) and the triple mutant (gbu1Δ agt1Δ car1Δ) were unable to grow on media
containing agmatine as the sole nitrogen source (Fig. 1B). Agmatine can act as an
immediate substrate for biosynthesis of putrescine, the diamine precursor of spermi-
dine and spermine. As a consequence, in higher eukaryotes that express arginine
decarboxylase (26), which converts arginine to agmatine, it participates in an alterna-
tive arginase-independent pathway for arginine catabolism and putrescine biosynthe-
sis (Fig. 1A). Alternatively, agmatine may be converted to GB which is then further
hydrolyzed to GABA by the enzyme 4-guanidinobutyrase (GBase), which we have
identified here as being encoded by GBU1 (orf19.3418) and which has recently been
reported in A. niger (25) and Kluyveromyces lactis (27). The finding that C. albicans
mutants lacking both GBU1 and AGT1, but not the corresponding single mutants, failed
to grow on agmatine is suggestive of parallel pathways for its utilization also existing
in C. albicans. The first pathway would involve the action of GBU1, which we have
shown to be required for the utilization of GB. The other pathway would involve the
conversion of agmatine to putrescine by agmatinase, and our finding that the mutants
lacking both GBU1 and AGT1 can utilize putrescine as a nitrogen source is therefore
consistent with AGT1 (orf19.5862) encoding an agmatinase. In addition, these findings
may exclude the possibility of there being an additional alternative route for pu-
trescene biosynthesis, for example, the agmatine deiminase system that converts
agmatine into putrescine via N-carbamoyl putrescine in a number of bacterial species
(28–31).
These growth assays therefore suggest that AGT1 and GBU1 do not encode argi-
nases but that CAR1 does. Car1 is therefore the only bona fide arginase in C. albicans;
this fungus has only one main catabolic pathway for arginine utilization, and this does
not appear to have a direct role in agmatine or GB catabolism. C. albicans, however, can
utilize agmatine and GB in an arginase-independent manner, and the utilization of
agmatine can occur either through its catabolism to GABA by GBase or its catabolism
to putrescine by an agmatinase.
Reduced arginase activity in car1 mutants does not affect arginase activity or
NO synthesis in macrophages. Consistent with the phenotype seen following growth
on arginine as a nitrogen source, the car1 knockout mutants showed significantly
reduced arginase activity following growth in rich media (Fig. 2A, red bars), whereas
none of the agt1 or gbu1 (single or double) mutants showed any change in arginase
activity (Fig. 2A, blue bars). In our previous work, we showed that C. albicans promotes
its survival in phagocytes by manipulating the availability of L-arginine (Fig. 2B), which
is required for nitrite oxide synthesis by the host (32). All three genes (CAR1, AGT1, and
GBU1) were previously shown to be induced strongly in macrophages (33). We there-
fore wanted to test whether C. albicans Car1, Agt1, and Gbu1 are involved in depleting
the macrophage L-arginine pool, thereby reducing the substrate for host inducible
nitrite oxide synthase (iNOS) and limiting the synthesis of the antimicrobial nitrite
oxide. When macrophages were stimulated with wild-type C. albicans, nitrite oxide
production was reduced; however, no statistically significant differences in NO reduc-
tion were observed in coculturing performed with any of the gene knockout mutants
(Fig. 2C). We next tested if the C. albicans arginase-like enzymes (Car1, Agt1, and Gbu1)
Arginase, Agmatinase, and Guanidinobutyrase in Candida ®
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FIG 2 Arginase activity in C. albicans ureohydrolase mutants plus arginase and iNOS activity during the macrophage interaction. (A) Arginase activity was
determined in protein extracts isolated from C. albicans cultures grown in YPD. (B) Schematic model of how C. albicans might compete for arginine in
competition with macrophages, leading to suppression of NO synthesis by inducing arginase activity (based on data from reference 32). (C) Macrophage
NO synthesis following costimulation with C. albicans wild-type and ureohydrolase mutant strains. (D) Macrophage-derived or total (macrophage and C.
albicans) arginase activity following costimulation with C. albicans wild-type cells. (E and F) Total (E) or macrophage-derived (F) arginase activity following
costimulation with C. albicans wild-type and ureohydrolase mutant strains. **, P  0.01; ***, P  0.001; ****, P  0.0001; ns, not statistically significant.
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impacted macrophage arginase activity following their engulfment. Using two methods
of cell breakage to release arginase, we prepared either macrophage-derived or total
(macrophage and C. albicans) protein extracts. Increased macrophage arginase activity
was seen under conditions of stimulation with wild-type C. albicans cells (Fig. 2D, red
bars), as described previously (32), and the total level of arginase activity detected was
3-fold higher (Fig. 2D, black bars) than that seen with macrophages alone. Consistent
with Car1 representing the sole arginase activity in C. albicans, this increase in total
arginase activity was not seen following costimulation with any of the mutants lacking
CAR1 (Fig. 2E). There were no other statistically significant differences in total arginase
activity following costimulation with the other mutant strains. Furthermore, no statis-
tically significant differences were seen in macrophage-derived arginase activity fol-
lowing costimulation with the C. albicans strains (Fig. 2F). Therefore, C. albicans Car1,
Agt1, and Gbu1 do not play a direct role in limiting host NO synthesis through substrate
limitation and were also not responsible for influencing macrophage arginase or iNOS
activity. Other factors produced by C. albicans must therefore lead to the increase in
macrophage arginase activity.
Candida arginase Car1 is important for arginine-induced hypha formation.
Arginine had previously been shown to be important for inducing hypha formation in
C. albicans through the cAMP-dependent protein kinase A (PKA) pathway (34). A
mutation of the urea amidolyase gene (DUR1,2), which functions downstream of
arginase and hydrolyses urea to NH3 and CO2, has been found to be defective in
arginine-induced hypha formation (34). The CO2 produced by this enzyme acts as a
signal to stimulate the yeast-to-hypha transition both in vivo and in macrophages (34,
35). Furthermore, the resulting alkalinization, through the release of NH3, results in a
transition from arginine synthesis to arginine catabolism, including increased CAR1
expression (36) (Fig. 3A). In addition, recent work showed that mitochondrion-
generated ATP, in accordance with the conversion of ornithine to proline and its
breakdown to glutamate, also plays a key role in arginine-induced morphogenesis and
induces hyphal growth more rapidly than the Dur1,2-generated CO2 (37) (Fig. 3A).
Finally, the breakdown of arginine can also fuel polyamine production, which may also
drive morphogenesis through the cAMP-PKA pathway. We therefore tested whether C.
albicans Car1, Gbu1, and Agt1 are also involved in arginine-induced hyphal develop-
ment and alkalinization (Fig. 3). To test for alkalinization, we performed a spot assay on
minimal media containing intermediate products of the pathways (Fig. 1A and B) and
the pH indicator bromocresol purple (Fig. 3C) to visualize a pH shift from below pH 5.2
(yellow) to above pH 6.8 (purple). We observed alkalization (purple), on medium where
arginine was the only nitrogen and carbon source, for the wild-type and gbu1Δ and
agt1Δ single and gbu1Δ agt1Δ double mutants (Fig. 3C, top images). No color change
was observed with the car1Δ single mutant and the gbu1Δ agt1Δ car1Δ triple mutant.
Alkalinization was abolished when ornithine was added to the medium as a nitrogen
and carbon source (Fig. 3C, bottom images). Therefore, the utilization of arginine but
not of agmatine or its derivatives leads to alkalinization.
For hypha formation studies, microscopy images were taken after 150 min of
induction at 37°C with either arginine or ornithine plus urea (Fig. 3B) or agmatine,
GABA, or GB (Fig. S3). Hypha formation was apparent for the wild-type strain and the
gbu1Δ and agt1Δ single and gbu1Δ agt1Δ double mutants following arginine induction
(Fig. 3B, top images). In contrast limited, hyphal growth was observed in the car1Δ
single and gbu1Δ agt1Δ car1Δ triple mutants, with the majority of the cells remaining
in the yeast morphology. Following ornithine and urea induction, all strains, including
the car1Δ single mutant and gbu1Δ agt1Δ car1Δ triple mutant, developed hyphae
(Fig. 3B, bottom images). GB and GABA were also strong inducers of hyphal develop-
ment, and all C. albicans mutants developed hyphae in their presence. In contrast,
agmatine appeared to be a weak inducer of hyphal development under the conditions
tested, and again, all of the mutants displayed similar responses (Fig. S3). We therefore
conclude that Car1 arginase activity is directly required for arginine-induced hyphal
Arginase, Agmatinase, and Guanidinobutyrase in Candida ®
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growth and that Car1, alongside Dur1,2, is involved in alkalinization of the environment
following growth on arginine.
C. albicans ureohydrolases are required for full virulence. We next tested whether
C. albicans AGT1, GBU1, and CAR1 are required for virulence, in both the Galleria
mellonella and Mus musculus infection models (Fig. 4). For G. mellonella, larvae were
infected with 8  104 cells of C. albicans and the survival rate was monitored over
7 days postinfection (Fig. 4A). The virulence of the car1Δ single mutant or gbu1Δ agt1Δ
double mutant was indistinguishable from that of the wild type (Fig. 4A). However, the
gbu1Δ agt1Δ car1Δ triple mutant displayed significantly reduced virulence and this was
rescued in the reintegrant control strain.
A range of mutants was also tested in a 3-day mouse model of systemic infection
(Fig. 4B; see also Fig. S4). For this test, CFU counts per gram of kidney tissue and weight
loss of the animal were recorded as indicators of disease progression, and the results
were combined to calculate a total outcome score (38). No major defect was apparent
for the car1Δ single mutant or gbu1Δ agt1Δ double mutant (Fig. S4). However, a
significant reduction in fungal burden (P  0.05) was detected for the triple mutant
(gbu1Δ agt1Δ car1Δ) and the animals demonstrated significantly reduced weight loss
relative to controls (P  0.01), resulting overall in a significantly reduced outcome score
(P  0.01). We have therefore demonstrated that AGT1, GBU1, and CAR1 together
FIG 3 Candida arginase CAR1 is required for hyphal growth and alkalinization. (A) Relationship between arginase activity and subsequent hyphal development
and alkalinization as described in the text. (B) Stationary-phase yeast cells were inoculated into induction media containing 0.17% YNB (minus ammonium
sulfate), 0.004% glucose, and a 10 mM concentration of either arginine or ornithine and urea. The microscope images shown are representative of results seen
after 150 min of incubation at 37°C. The scale bar is 10 m. (C) C. albicans ureohydrolase mutant spot assay performed on media containing the pH indicator
bromocresol purple and either arginine or ornithine as a sole nitrogen and carbon source. Images were taken after 4 days of incubation at 30°C. The scale bar
is 5 mm.
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contributed to the virulence of C. albicans in both wax moth and mouse infection
models.
DISCUSSION
The objective of this study was to understand the role of arginine metabolism in the
Candida-host interaction. Previously, we had shown that macrophages that engulf C.
albicans, or fungal cell wall chitin, induce host arginase activity (32). This activation
could in turn result in protection of the phagocytosed fungus from iNOS, which also
uses arginine as a substrate to generate nitric oxide. In addition to the host arginase
genes, there are also three genes with high similarity to those encoding arginases in the
C. albicans genome (CAR1, AGT1, and GBU1). However, these also display sequence
similarity to other arginase-like encoding genes, including agmatinase genes; as such,
it was necessary to establish what these gene products were and what role they have
in C. albicans development and host interaction. We found that none of these enzymes
had an impact on host NO production, either directly via substrate depletion or
FIG 4 C. albicans arginases family members are required for full virulence in a Galleria mellonella infection model
and in a mouse model (Mus musculus) of systemic infection. (A) Survival rate of G. mellonella larvae infected with
8  104 cells of C. albicans. Virulence of the wild-type strain and car1Δ single, gbu1Δ agt1Δ double, and gbu1Δ
agt1Δ car1Δ triple null mutant strain and of the associated reintegrant control strain was followed for 7 days in a
Galleria infection model. Reduced virulence was documented for the gbu1Δ agt1Δ car1Δ triple mutant. (B) Virulence
of the wild-type, triple null mutant, and reintegrant strains in a 3-day mouse model of systemic infection. Mice were
infected with 7.4  104 to 7.9  104 CFU/g through lateral tail vein infection and sacrificed after 3 days, and the
kidney burden (log10 CFU/g), percent weight loss, and outcome score (based on both kidney burden and weight
loss) were calculated. (**, P  0.01; *, P  0.05).
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indirectly through host arginase induction or host iNOS repression. Through nitrogen
assimilation profiling of mutants with mutations in these genes, we found that only
CAR1 encodes a bona fide arginase in C. albicans. We propose here that the other two
open reading frames, orf19.5862 and orf19.3418, encode agmatinase (Agt1) and gua-
nidinobutyrase (Gbu1), respectively, based on the ability of our set of mutants to utilize
specific nitrogen substrates. While arginase metabolism and arginine metabolism have
been studied in a range of fungal species (39), relatively little is known about the role
of agmatinase or guanidinobutyrase in fungi.
Recently, agmatinase was characterized in the filamentous fungus Neurospora crassa
(AGM-1) and it was shown to have an impact on F-actin dynamics and to play an
essential role in cell development (40). Interestingly, N. crassa Δagm-1 null mutants
were unable to grow and the heterokaryon strain showed reduced hypha elongation,
conidiation, and biomass production despite retaining ornithine decarboxylase activity
(40). Arginine decarboxylase, the enzyme that produces the agmatine for agmatinase,
whose decarboxylation yields putrescine, has previously been described in bacteria (41,
42), animals (43), and plants (44). Our searches revealed no arginine decarboxylase
homologue in C. albicans, confirming that only four fungi have been identified to have
arginine decarboxylase to date (7–9). It may be that the absence of arginine decarbox-
ylase is correlated with the occurrence of ornithine decarboxylase and indicates that
fungi normally synthesize putrescine directly by decarboxylation of ornithine. Plants
and archaebacteria may also form putrescine from agmatine via agmatine deiminase
and N-carbamyl-putrescine hydrolase (45, 46). However, no homologous gene or
evidence for this activity has been found in C. albicans. In K. lactis, an alternative
arginase-independent pathway for arginine metabolism has been described that may
be widespread in fungi (27). This pathway involves the transamination of arginine to
ketoarginine, which is then decaboxylated to guanidinobutanal and oxidized to
4-guanidinobutyrate (4-guanidinobutyric acid or GB). This pathway for arginine catab-
olism would operate as an alternative to the arginine decarboxylase that is absent in
fungi and would also provide a potential alternative to ornithine decarboxylase.
Deletion of the arginase gene CAR1 in C. albicans did not completely abolish growth on
arginine as a sole nitrogen source, as background growth of the car1Δ mutant was
maintained on this medium. This may suggest that C. albicans may also have an
alternative pathway for arginine catabolism, potentially through ketoarginine activity as
described in K. lactis.
We show that GB could be used as the sole nitrogen source by C. albicans, as has
also been described for Penicillium roqueforti (47) A. niger (25), and K. lactis but not S.
cerevisiae (27). Indeed, GBase, the enzyme that catalyzes the hydrolysis of GB to GABA
and urea, has been shown to be widespread in fungi (27), although it is absent in some
Saccharomycetaceae clades, including the majority of S. cerevisiae strains sequenced
(27). In K. lactis, the KlGBU1 gene was originally described as encoding an arginase-like
enzyme before its true biochemical activity was revealed. It is the homolog of
orf19.3418 (GBU1) in C. albicans, which we describe here as acting as a GBase gene.
We show that C. albicans can utilize agmatine as a sole nitrogen source via two
independent pathways (Fig. 1A). First, agmatine catabolism can occur via the guanidi-
nobutyrase (Gbu1) pathway that produces GABA and succinate. Alternatively, agmati-
nase may act to produce putrescine from agmatine. The action of an agmatinase would
represent an alternative to the arginase and ornithine decarboxylase pathway that
ultimately yields polyamines or GABA. These arginase-independent pathways link
agmatine to succinate, either through putrescine by agmatinase activity or guanidi-
nobutyrase by GBase activity. It is not known whether C. albicans can synthesize
agmatine, but we show that this fungus is capable of assimilating externally provided
agmatine via agmatinase or guanidinobutyrase (GBase; GBU1). Although the physio-
logical significance of these pathways is not clear, they may provide potential growth
advantages under conditions in which C. albicans encounters agmatine as a source of
carbon and nitrogen. In fungi that have all three enzymes, agmatinase and guanidi-
nobutyrase are predicted to be secreted enzymes whereas arginase is cytoplasmic. It
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may be that Car1 is required for central intracellular metabolism, whereas the others
may function to scavenge carbon and nitrogen from the environment by breaking
down complex nutrients such as agmatine. Alternatively, uptake of agmatine and GB
may be limited, and their utilization would consequently be dependent on initial
extracellular degradation.
Agmatine has been detected in many organs in rats, but the stomach (71 ng g1
wet weight), small intestine (55 ng g1), and large intestine (28 ng g1) have the
highest agmatine tissue concentrations (48, 49). The agmatine present in the lumen of
the human gastrointestinal tract is derived from three sources (19). Agmatine is
produced and released by gut bacteria of the human microbiome (18, 50, 51) or from
ingested food (19), or luminal agmatine derives from desquamated intestinal epithelial
cells (18). Therefore, the ability of C. albicans to utilize agmatine may provide a fitness
benefit for the fungus in the human host. In S. cerevisiae fermentation, it is known that
arginine catabolism is also involved in the production of proline, which cannot be
assimilated under anaerobic conditions (52). Arginine catabolism occurring through the
guanidinobutyrase pathway could therefore provide a selective advantage under an-
aerobic and nitrogen-limited conditions.
Polyamines (putrescine and spermidine) are important metabolites of intestinal
bacteria in humans, and the concentrations of putrescine in the intestinal lumen of
a healthy individual range from 0.5 to 1 mM (53, 54). Food-derived polyamines are
normally absorbed before they reach the lower intestine (55); therefore, most poly-
amines in the large intestine are derived from the intestinal microbiota (56). A novel
pathway for putrescine production from arginine through agmatine has been reported
that involves the collaboration of two bacterial species and is triggered by environ-
mental acidification (57). In this pathway, arginine can be taken up from the environ-
ment by Escherichia coli (arginine-dependent acid resistance system) and converted by
arginine decarboxylase to agmatine, which is then exported to the medium (57).
Bacteria that have the agmatine deiminase system, such as Enterococcus faecalis, can
then take up the released agmatine and convert it to putrescine. In silico metagenome
analysis of the most abundant bacterial species in the human microbiome (58) has
suggested that many species are unable to produce putrescine from arginine (59, 60),
indicating that agmatine metabolism may involve a consortium of cross-feeding bac-
teria. It may be that similar interspecies metabolic communication occurs between C.
albicans and bacteria of the intestinal microbiota, where the fungus is able to assimilate
bacterially produced agmatine.
In addition, agmatine can serve as an endogenous human cell-signaling molecule
that triggers an innate immune response, which can enhance the immune response
during infection (28, 61). It might be that organisms that express agmatine-degrading
enzymes possess a mechanism that potentially evades this component of the human
immune system. A similar role for Helicobacter pylori arginase has been proposed where
the depletion of arginine attenuates the innate immune response (62). It is therefore
possible that C. albicans utilization of agmatine may indirectly dampen the host
immune response.
Conclusion. The results presented suggest a novel route for polyamine metabolism
and agmatine assimilation in the fungal pathogen C. albicans. We show that agmatine
can be assimilated by C. albicans using two independent ureohydrolase-dependent
pathways that use agmatinase or guanidinobutyrase. The ureohydrolase family that we
posit, comprising arginase (Car1), agmatinase (Agt1), and guanidinobutyrase (Gbu1),
represents an enzyme set whose members are collectively essential for C. albicans
virulence. This set of ureohydrolases does not affect macrophage arginase or iNOS
activity and also does not function in protection from the phagocytic burst but enables
arginine and arginine-like substrates to support growth during pathogenesis.
MATERIALS AND METHODS
Strains and culture condition. C. albicans strains used in this work are listed in Table 1 and were
maintained as glycerol stocks at 70°C. Cells were grown in YPD medium (1% [wt/vol] yeast extract, 2%
Arginase, Agmatinase, and Guanidinobutyrase in Candida ®
July/August 2020 Volume 11 Issue 4 e01845-20 mbio.asm.org 11
 o
n
 Septem
ber 9, 2020 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
[wt/vol] peptone, 2% dextrose) at 30°C and 200 rpm. When solid medium was required, 2% (wt/vol) agar
was added. Cells from overnight cultures (YPD at 30°C, 200 rpm) were used to inoculate fresh YPD broth
until the exponential-growth phase was reached. Cells were collected, washed twice with phosphate-
buffered saline (PBS), counted, and used for costimulation of macrophages. To generate mutants using
the CRISPR-Cas9 strategy, transformants were selected on YPD agar supplemented with 200 g/ml
nourseothricin (ClonNAT; Werner BioAgents, Jena, Germany). For generation of the mutant strains by the
use of a URA3 recyclable PCR-mediated gene disruption system (23), transformants were selected on
SC-U medium (0.67% yeast nitrogen base [YNB], 2% glucose, 0.077% complete supplement mixture
minus uracil). The URA3 marker was then recycled through selection on SC-U medium plus 5-fluoroorotic
acid (2 mg/ml) and uridine (50 g/ml). For spot assay, cells were grown in minimal medium (2% glucose,
0.17% YNB [without amino acids and ammonium sulfate], 10 mM NH4SO4) washed twice with H2O, and
spotted on minimal agar media (2% agar [without NH4SO4]) containing 10 mM concentrations of the
indicated nitrogen sources. Solutions of urea (Sigma, CAS 57-13-6), ornithine (Sigma, CAS 3184-13-2),
arginine (Sigma, CAS 74–75-3), agmatine (Sigma, CAS 2482-00-0), 4-guanidinobutyrate (GB; Santa Cruz
Biotechnology, CAS 463-00-3), 4-aminobutyrate (GABA; Sigma, CAS 56-12-2), and putrescine (Sigma, CAS
333-93-7) were subjected to sterile filtration and added to the media after autoclaving. To monitor
alkalinization, the pH indicator bromocresol purple (Sigma, CAS 115-40-2) was added (0.01%) to medium
with or without glucose as a carbon source. YPD and minimal medium containing 10 mM NH4SO4 served
as the control. Prior to virulence testing, strains were grown in NGY medium (0.1% neopeptone, 0.4%
glucose, 0.1% yeast extract) at 30°C for 16 h.
Cells of the RAW 264.7 (ATCC TIB-71) murine macrophage cell line were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma), supplemented with 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin, and 10% (vol/vol) fetal bovine serum, at 37°C and 5% (vol/vol) CO2. After
reaching 90% confluence, cells were washed with PBS to remove dead cells and detached using 10 mM
EDTA and 4 mg/ml lidocaine–HCl–PBS for 5 to 10 min. Cells were harvested (10 min, 300  g) and either
reinoculated for further cultivating or subseeded into 12-well plates at a density of 5  105 cells/well in
the media described above supplemented with 1% minimum essential medium (MEM) and nonessential
amino acids (NEAA; Gibco) (100) and left overnight to adhere. Macrophages were activated with
100 ng/ml gamma interferon (IFN-) and lipopolysaccharide (LPS) 4 h prior to coincubation with
2.5  106 C. albicans cells (macrophage/yeast cell ratio of 1:5) for 3 h. Supernatant was collected and
stored at –20°C for arginase activity and nitric oxide measurements.
Genetic manipulation. For gene disruption using the CRISPR-Cas9 strategy, C. albicans strain SC5314
(63) was used as the parental strain. The CaCas9 Solo system (pV1200 vector) was used in this work, and
constructions of knockout and reconstitution vectors, marker recycling, and verification of CRISPR-
mutagenized loci were performed according to a previously described method (24, 64). Briefly, single
guide RNA (sgRNA) sequences were selected (the sequences can be found at http://osf.io/ARDTX)
targeting the C. albicans open reading frame of interest directly upstream of a NGG protospacer-adjacent
motif (PAM) site. Overhang sequences of annealed and phosphorylated 20-base forward and comple-
ment reverse guide oligonucleotides were ligated into CIP (calf intestinal phosphatase-treated BsmBI-
digested pV1200 parent vector, and correct clones were identified by sequencing. The vector (5 to 10 g)
was then linearized by digestion with KpnI and SacI before transformation was performed for efficient
targeting to the ENO1 locus. Transformation was performed along with processing using a purified repair
template (3 g) that was generated with 60-bp oligonucleotide primers containing a 20-bp overlap at
their 3= ends centered on the desired mutation point. Homozygous mutations (introduced restriction
site, stop codon, a frameshift, and mutation of the corresponding PAM) were verified by sequencing
(GENEWIZ; Takeley Sanger Sequencing Laboratory, United Kingdom). Reconstitution of the wild-type
genotype from the null mutant background was performed with the CRSIPR-Cas9 transformation
protocol described above. Both alleles were restored to the wild-type form (involving removal of the
introduced restriction site, the mutated PAM, and the stop codon and correction of the frameshift).
However, the reconstituted wild-type strains included the introduction of a silent PAM mutation. The
genotypes of the transformants were verified by sequencing. Details of the primer sequences used are
listed in Table S2 and Table S3.
Gene disruption was also conducted using the PCR-directed mini-URA blaster method as previously
reported (23). Briefly, disruption cassettes were amplified from plasmid pDDB57 using long primers
(Table S4) containing 70 bp of sequence with homology to the target ORF. Mutants were made through
the sequential transformation of the disruption cassettes and recycling of the URA3 marker through
selection on 5-fluoroorotic acid. Ultimately, to avoid issues associated with the ectopic expression of
URA3, the URA3 marker was integrated into the RPS1 locus of all mutants by transformation with
StuI-digested CIp10 plasmid (65). For reintegrant controls, the genes, plus 1,000 bp upstream and
500 bp downstream, were PCR amplified and cloned into the XbaI, NotI, or HindIII site of CIp10 for
CAR1, GBU1, or AGT1, respectively. The required double and triple reintegrant control vectors were made
through sequential cloning, and the vectors were ultimately linearized through digestion with StuI and
integrated at the RPS1 locus.
Phenotypic characterization of mutants. For spot assays, exponentially growing cells were har-
vested from minimal medium at 30°C, washed twice with deionized water, and adjusted to an optical
density (OD) of 0.1. The samples were then serially diluted, and 3 l was spotted onto the different
media. Plates were incubated at 30°C, checked at regular intervals, and scanned after 72 h (except for the
YPD and arginine-containing media, where end points were recorded after 48 h and 96 h, respectively).
For hyphal induction, strains were grown initially in minimal medium (0.67% YNB, 2% glucose) for 24 h;
the cells were then washed and inoculated into prewarmed induction media at 1  106 cells/ml and
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incubated at 37°C for 150 min. The induction media consisted of 0.17% YNB (minus ammonium sulfate)
and 0.004% glucose supplemented with either 20 mM arginine, 20 mM urea and ornithine, 20 mM
agmatine, 20 mM 4-guanidinobutyrate (GB), or 20 mM 4-aminobutyrate (GABA).
Macrophage and C. albicans cocultures were washed once with ice-cold PBS before macrophages
were lysed for 10 min by adding 200 l of 0.4% Triton X-100–10 mM Tris-HCl (pH 7.4) supplemented with
fresh 1 M pepstatin A and 1 M leupeptin in each well. Samples were collected, transferred into
centrifugation tubes, and centrifuged for 10 min at 4°C and 13,000 rpm to remove cellular debris. Lysates
were transferred into fresh tubes and stored at 20°C until analyzed. For Candida cell lysis, protein lysis
buffer (50 mM Tris, 150 mM NaCl, 10 mM imidazole, and 0.1% NP-40, with freshly added protease
inhibitors [1 M pepstatin A and 1 M leupeptin]) was added to each well and incubated 5 min on ice.
Cells were scraped from the surface and transferred into cold centrifugation tubes, snap-frozen in liquid
nitrogen, and stored at –20°C before protein extraction. Pellets were thawed at 4°C, washed, and
resuspended in 350 l ice-cold lysis buffer and transferred to a ribolyser tube containing 1 ml chilled
glass beads. Samples were disrupted by bead beating (BioSpec) performed twice for 15 s each time.
Protein concentrations were determined using Bradford reagent (Bio-Rad standard assay in microplates).
Arginase activity and nitric oxide concentrations in supernatants and cell lysates were determined using
an arginase activity assay kit (Sigma-Aldrich) and a Griess reagent kit for nitrite determination (Molecular
Probes) according to the instructions of the manufacturers.
Statistical analysis. Multiple-protein-sequence alignment (see Fig. S1A in the supplemental mate-
rial) was performed using MUSCLE (66), and the results were used to calculate the percentages of identity
of the three proteins (Fig. S1B). OMA (Orthologous MAtrix) database v2.3.0 (67) was used to identify
orthologues among publicly available (see Table S1 in the supplemental material), complete genome
sequences and identified pairwise orthologues between all pairs of species in the analysis (Fig. S1C). To
guarantee that a significant fraction of a sequence was aligned, a length tolerance criterion was used.
According to the criterion used, the length of the shorter aligned sequence was required to represent at
least fraction  of the longest sequence. The relationship was expressed as minimum (|a1|, |a2|) 
·maximum (|s1|, |s2|), where a1 and a2 are the lengths of the aligned subsequences of s1 and s2.
Alignments that satisfy both the length and score criteria are upgraded to candidate pairs (CP). OMA was
run with default parameters apart from the length tolerance criterion, which was lowered from 0.61
(default) to 0.45 to include the manually identified BLAST results (80% identity; E value  1e70; bit
score  250) corresponding to a C. auris ortholog that was truncated to 0.5 the length of C. albicans
CAR1 (194 amino acids compared to 319 for C. albicans CAR1).
Statistical analyses of G. mellonella and M. musculus virulence assay results (Fig. 4) were performed
using GraphPad Prism 5 software. All the G. mellonella experiments were performed with three biological
replicates in duplicate. Data represent cumulative results of all experiments performed, and errors were
calculated as means  standard deviations (SD). Log rank tests were conducted for the G. mellonella
survival assays, and analysis of variance (ANOVA) or Dunnett’s test was used for the M. musculus model
to establish statistical significance, which was set at a P value of 0.05.
Virulence assay. Galleria mellonella larvae were purchased from the United Kingdom (Waxworms
Ltd., Sheffield, United Kingdom). Groups of 20 healthy larvae (0.25 to 0.35 g) were inoculated through the
last left proleg into the hemocoel with 10 l of cell suspension (8  104 cells/larva) using a Hamilton
syringe. Following infection, larvae were incubated in the dark at 37°C and survival was monitored daily
for 7 days on the basis of responses to physical stimulation and melanization. Larvae inoculated with PBS
were used as uninfected controls, and the experiments performed with the uninfected controls resulted
in no deaths. Assays were performed at least 3 times independently (Fig. 4A). Female BALB/c mice were
originally purchased from Charles River, United Kingdom, and provided with food and water ad libitum.
Mice were infected with an infectious dose of 7.4  104 to 7.9  104 CFU/g through a lateral tail vein and
were humanely sacrificed after 3 days, and the kidney burden (log10 CFU/ml), percent weight loss, and
outcome score (38) (based on both kidney burden and weight loss) were calculated (**, P  0.01; *,
P  0.05).
SUPPLEMENTAL MATERIAL
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FIG S2, TIF file, 0.3 MB.
FIG S3, TIF file, 0.5 MB.
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